Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study
Monica Nabil Nakhla,1 Ria Patel,1 Estelle Crowley,2 Yichen Li,3 Thelge Buddika Peiris,3 Daniel Brocks2 1Tufts University School of Medicine, Boston, MA, USA; 2Department of Ophthalmology, BostonSight, Needham, MA, USA; 3Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester,...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/utilizing-prose-as-a-drug-delivery-device-for-preservative-free-cyclos-peer-reviewed-fulltext-article-OPTH |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850194783758188544 |
|---|---|
| author | Nakhla MN Patel R Crowley E Li Y Peiris TB Brocks D |
| author_facet | Nakhla MN Patel R Crowley E Li Y Peiris TB Brocks D |
| author_sort | Nakhla MN |
| collection | DOAJ |
| description | Monica Nabil Nakhla,1 Ria Patel,1 Estelle Crowley,2 Yichen Li,3 Thelge Buddika Peiris,3 Daniel Brocks2 1Tufts University School of Medicine, Boston, MA, USA; 2Department of Ophthalmology, BostonSight, Needham, MA, USA; 3Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, MA, USACorrespondence: Daniel Brocks, Department of Ophthalmology, BostonSight, Needham, MA, USA, Tel +1 781 726 7337, Fax +1 781 726 7310, Email dbrocks@bostonsight.orgPurpose: To evaluate the tolerability of utilizing Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) as a drug delivery device for preservative-free cyclosporine 0.05% for the treatment of dry eye disease.Patients and Methods: Fourteen current daily PROSE wearers were enrolled, with four screen failures and one subject that did not complete the study protocol due to burning and stinging. Nine subjects, 18 eyes completed the study protocol. All participants were instructed to instill one drop of preservative-free cyclosporine 0.05% in the PROSE reservoir and then fill the rest of the reservoir with preservative-free normal saline. After applying the PROSE and wearing for 6 hours, the PROSE was removed, and the protocol was repeated for at least another 4 additional hours of wear. Baseline, 1 week and 1 month symptom and sign data were collected.Results: At one month, OSDI improved by an average of 3.83 ± 6.87 from baseline (p = 0.07) and there was no statistically significant change in best corrected visual acuity. Without comparing with placebo, there was statistically significant (p < 0.05) improvement in mean per subject and mean per eye corneal fluorescein staining, conjunctival lissamine staining, and conjunctival hyperemia by slit lamp examination at one-month follow-up.Conclusion: Utilizing PROSE as a drug delivery system for non-preserved cyclosporine 0.05% was well tolerated in regard to both ocular symptoms and ocular surface signs. Results from this pilot study are suggestive of efficacy. The results of this study support progressing this protocol to a larger scale randomized controlled double blinded prospective clinical trial.Keywords: ocular surface disease, scleral lens, keratoconjunctivitis sicca, corneal staining |
| format | Article |
| id | doaj-art-59c4f1a97fce4a029423b5ce2155b8d8 |
| institution | OA Journals |
| issn | 1177-5483 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Ophthalmology |
| spelling | doaj-art-59c4f1a97fce4a029423b5ce2155b8d82025-08-20T02:13:55ZengDove Medical PressClinical Ophthalmology1177-54832024-11-01Volume 183203321397126Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot StudyNakhla MNPatel RCrowley ELi YPeiris TBBrocks DMonica Nabil Nakhla,1 Ria Patel,1 Estelle Crowley,2 Yichen Li,3 Thelge Buddika Peiris,3 Daniel Brocks2 1Tufts University School of Medicine, Boston, MA, USA; 2Department of Ophthalmology, BostonSight, Needham, MA, USA; 3Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, MA, USACorrespondence: Daniel Brocks, Department of Ophthalmology, BostonSight, Needham, MA, USA, Tel +1 781 726 7337, Fax +1 781 726 7310, Email dbrocks@bostonsight.orgPurpose: To evaluate the tolerability of utilizing Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) as a drug delivery device for preservative-free cyclosporine 0.05% for the treatment of dry eye disease.Patients and Methods: Fourteen current daily PROSE wearers were enrolled, with four screen failures and one subject that did not complete the study protocol due to burning and stinging. Nine subjects, 18 eyes completed the study protocol. All participants were instructed to instill one drop of preservative-free cyclosporine 0.05% in the PROSE reservoir and then fill the rest of the reservoir with preservative-free normal saline. After applying the PROSE and wearing for 6 hours, the PROSE was removed, and the protocol was repeated for at least another 4 additional hours of wear. Baseline, 1 week and 1 month symptom and sign data were collected.Results: At one month, OSDI improved by an average of 3.83 ± 6.87 from baseline (p = 0.07) and there was no statistically significant change in best corrected visual acuity. Without comparing with placebo, there was statistically significant (p < 0.05) improvement in mean per subject and mean per eye corneal fluorescein staining, conjunctival lissamine staining, and conjunctival hyperemia by slit lamp examination at one-month follow-up.Conclusion: Utilizing PROSE as a drug delivery system for non-preserved cyclosporine 0.05% was well tolerated in regard to both ocular symptoms and ocular surface signs. Results from this pilot study are suggestive of efficacy. The results of this study support progressing this protocol to a larger scale randomized controlled double blinded prospective clinical trial.Keywords: ocular surface disease, scleral lens, keratoconjunctivitis sicca, corneal staininghttps://www.dovepress.com/utilizing-prose-as-a-drug-delivery-device-for-preservative-free-cyclos-peer-reviewed-fulltext-article-OPTHocular surface diseasescleral lenskeratoconjunctivitis siccacorneal staining |
| spellingShingle | Nakhla MN Patel R Crowley E Li Y Peiris TB Brocks D Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study Clinical Ophthalmology ocular surface disease scleral lens keratoconjunctivitis sicca corneal staining |
| title | Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study |
| title_full | Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study |
| title_fullStr | Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study |
| title_full_unstemmed | Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study |
| title_short | Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study |
| title_sort | utilizing prose as a drug delivery device for preservative free cyclosporine 0 05 for the treatment of dry eye disease a pilot study |
| topic | ocular surface disease scleral lens keratoconjunctivitis sicca corneal staining |
| url | https://www.dovepress.com/utilizing-prose-as-a-drug-delivery-device-for-preservative-free-cyclos-peer-reviewed-fulltext-article-OPTH |
| work_keys_str_mv | AT nakhlamn utilizingproseasadrugdeliverydeviceforpreservativefreecyclosporine005forthetreatmentofdryeyediseaseapilotstudy AT patelr utilizingproseasadrugdeliverydeviceforpreservativefreecyclosporine005forthetreatmentofdryeyediseaseapilotstudy AT crowleye utilizingproseasadrugdeliverydeviceforpreservativefreecyclosporine005forthetreatmentofdryeyediseaseapilotstudy AT liy utilizingproseasadrugdeliverydeviceforpreservativefreecyclosporine005forthetreatmentofdryeyediseaseapilotstudy AT peiristb utilizingproseasadrugdeliverydeviceforpreservativefreecyclosporine005forthetreatmentofdryeyediseaseapilotstudy AT brocksd utilizingproseasadrugdeliverydeviceforpreservativefreecyclosporine005forthetreatmentofdryeyediseaseapilotstudy |